Rx drug information, pharmaceutical research, clinical trials, news, and more
A drug interaction study was performed in which Erbitux was administered in combination with irinotecan. There was no evidence of any pharmacokinetic interactions
between Erbitux and irinotecan.
The maximum single dose of Erbitux administered is 1000 mg/m2 in one patient. No adverse events were reported for this patient.
All Rights reserved - Copyright DrugLib.com, 2006-2017